155 related articles for article (PubMed ID: 30362427)
1. [Role of ST2 biomarker for the evaluation of myocardial remodeling in patients with ischemic heart failure with preserved ejection fraction].
Kop'eva KV; Teplyakov AT; Grakova EV; Soldatenko MV; Ogurkova ON; Ahmedov SD
Kardiologiia; 2018 SOct; (S10):33-43. PubMed ID: 30362427
[TBL] [Abstract][Full Text] [Related]
2. Prognostic role of ST2 in patients with chronic heart failure of ischemic etiology and carbohydrate metabolism disorders.
Grakova EV; Kopeva KV; Teplyakov AT; Ogurkova ON; Garganeeva AA; Garmaeva OV
Ter Arkh; 2019 Mar; 91(1):32-37. PubMed ID: 31090368
[TBL] [Abstract][Full Text] [Related]
3. Ability of soluble ST2 to predict left ventricular remodeling in patients with acute coronary syndrome.
Park S; Kim IC; Kim H; Cho YK; Lee CH; Hur SH
Heart Vessels; 2022 Feb; 37(2):173-183. PubMed ID: 34341876
[TBL] [Abstract][Full Text] [Related]
4. Soluble ST2 protein and hospitalizations due to worsening chronic heart failure during a one-year follow-up in a population with reduced ejection fraction.
Wojtczak-Soska K; Sakowicz A; Pietrucha T; Janikowski K; Lelonek M
Adv Clin Exp Med; 2017 Sep; 26(6):931-938. PubMed ID: 29068593
[TBL] [Abstract][Full Text] [Related]
5. Soluble ST2 Receptor: Biomarker of Left Ventricular Impairment and Functional Status in Patients with Inflammatory Cardiomyopathy.
Obradovic DM; Büttner P; Rommel KP; Blazek S; Loncar G; von Haehling S; von Roeder M; Lücke C; Gutberlet M; Thiele H; Lurz P; Besler C
Cells; 2022 Jan; 11(3):. PubMed ID: 35159224
[TBL] [Abstract][Full Text] [Related]
6. Serum soluble ST2: a potential novel mediator in left ventricular and infarct remodeling after acute myocardial infarction.
Weir RA; Miller AM; Murphy GE; Clements S; Steedman T; Connell JM; McInnes IB; Dargie HJ; McMurray JJ
J Am Coll Cardiol; 2010 Jan; 55(3):243-50. PubMed ID: 20117403
[TBL] [Abstract][Full Text] [Related]
7. [Diagnostic value of combining serum soluble ST2 and interleukin-33 for heart failure patients with preserved left ventricular ejection fraction].
Luo NS; Zhang HF; Liu PM; Lin YQ; Huang TC; Yang Y; Wang JF
Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Mar; 45(3):198-203. PubMed ID: 28316175
[No Abstract] [Full Text] [Related]
8. Prognostic value of soluble ST2 biomarker in heart failure patients with reduced ejection fraction - A multicenter study.
Bahuleyan CG; Alummoottil GK; Abdullakutty J; Lordson AJ; Babu S; Krishnakumar VV; Pillai AM; Abraham G; Dilip MN
Indian Heart J; 2018 Jul; 70 Suppl 1(Suppl 1):S79-S84. PubMed ID: 30122243
[TBL] [Abstract][Full Text] [Related]
9. The Effectiveness of Outpatient Treatment Under the Control of the Soluble ST2 Receptor Concentration in Patients With Heart Failure With Reduced Ejection Fraction After Acute Decompensation of Heart Failure.
Muksinova MD; Narusov OY; Sychev AV; Sharf TV; Masenko VP; Tereshchenko SN; Skvortsov AA
Kardiologiia; 2023 Dec; 63(12):87-92. PubMed ID: 38156496
[TBL] [Abstract][Full Text] [Related]
10. Heart failure with preserved left ventricular ejection fraction in patients with obstructive sleep apnea syndrome: prognostic value of biomarkers.
Grakova EV; Yakovlev AV; Shilov SN; Berezikova EN; Kopeva KV; Yakovleva NF; Ogurkova ON; Teplyakov AT
Kardiologiia; 2021 Nov; 61(11):77-88. PubMed ID: 34882081
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-1 receptor-related protein ST2 and mitral valve repair outcome in patients with chronic degenerative mitral regurgitation.
Galeone A; Lessana A; Mascolo E; Di Serio F; Marraudino N; Laborde F; Paparella D
Thorac Cardiovasc Surg; 2014 Feb; 62(1):47-51. PubMed ID: 24065602
[TBL] [Abstract][Full Text] [Related]
12. sST2 as a New Biomarker of Chronic Kidney Disease-Induced Cardiac Remodeling: Impact on Risk Prediction.
Plawecki M; Morena M; Kuster N; Chenine L; Leray-Moragues H; Jover B; Fesler P; Lotierzo M; Dupuy AM; Klouche K; Cristol JP
Mediators Inflamm; 2018; 2018():3952526. PubMed ID: 30402040
[TBL] [Abstract][Full Text] [Related]
13. Soluble ST2 reflects hemodynamic stress in non-ischemic heart failure.
Broch K; Andreassen AK; Ueland T; Michelsen AE; Stueflotten W; Aukrust P; Aakhus S; Gullestad L
Int J Cardiol; 2015 Jan; 179():378-84. PubMed ID: 25464491
[TBL] [Abstract][Full Text] [Related]
14. Soluble ST2 protein in the short-term prognosis after hospitalisation in chronic systolic heart failure.
Wojtczak-Soska K; Sakowicz A; Pietrucha T; Lelonek M
Kardiol Pol; 2014; 72(8):725-34. PubMed ID: 24846354
[TBL] [Abstract][Full Text] [Related]
15. Soluble ST2 for predicting sudden cardiac death in patients with chronic heart failure and left ventricular systolic dysfunction.
Pascual-Figal DA; Ordoñez-Llanos J; Tornel PL; Vázquez R; Puig T; Valdés M; Cinca J; de Luna AB; Bayes-Genis A;
J Am Coll Cardiol; 2009 Dec; 54(23):2174-9. PubMed ID: 19942089
[TBL] [Abstract][Full Text] [Related]
16. Biologic Variability of Soluble ST2 in Patients With Stable Chronic Heart Failure and Implications for Monitoring.
Piper S; deCourcey J; Sherwood R; Amin-Youssef G; McDonagh T
Am J Cardiol; 2016 Jul; 118(1):95-8. PubMed ID: 27189812
[TBL] [Abstract][Full Text] [Related]
17. The integrated value of sST2 and global longitudinal strain in the early stratification of patients with severe aortic valve stenosis: a translational imaging approach.
Fabiani I; Conte L; Pugliese NR; Calogero E; Barletta V; Di Stefano R; Santoni T; Scatena C; Bortolotti U; Naccarato AG; Petronio AS; Di Bello V
Int J Cardiovasc Imaging; 2017 Dec; 33(12):1915-1920. PubMed ID: 28664478
[TBL] [Abstract][Full Text] [Related]
18. Soluble ST2 Levels and Left Ventricular Structure and Function in Patients With Metabolic Syndrome.
Celic V; Majstorovic A; Pencic-Popovic B; Sljivic A; Lopez-Andres N; Roy I; Escribano E; Beunza M; Melero A; Floridi F; Magrini L; Marino R; Salerno G; Cardelli P; Di Somma S
Ann Lab Med; 2016 Nov; 36(6):542-9. PubMed ID: 27578507
[TBL] [Abstract][Full Text] [Related]
19. Serial soluble ST2 for the monitoring of pharmacologically optimised chronic stable heart failure.
Piper SE; Sherwood RA; Amin-Youssef GF; Shah AM; McDonagh TA
Int J Cardiol; 2015 Jan; 178():284-91. PubMed ID: 25465308
[TBL] [Abstract][Full Text] [Related]
20. The Interleukin-33/ST2 Pathway Is Expressed in the Failing Human Heart and Associated with Pro-fibrotic Remodeling of the Myocardium.
Tseng CCS; Huibers MMH; van Kuik J; de Weger RA; Vink A; de Jonge N
J Cardiovasc Transl Res; 2018 Feb; 11(1):15-21. PubMed ID: 29285671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
